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Abstract 
In the middle of the last century, it has been known that neural stem cells (NSCs) play a key 
role in regenerative medicine to cure the neurodegenerative disease. This review article covers 
about the introduction to neural stem cell biology and the isolation, differentiation and 
transplantation methods/techniques of neural stem cells. The neural stem cells can be 
transplanted into the human brain in the future to replace the damaged and dead neurons. The 
highly limited access to embryonic stem cells and ethical issues have escalated the search for 
other NSC sources. The developing technologies are indicating that it can be achieved before 
the end of this century. In addition, the differentiation and the maturation of NSCs can 
artificially accelerate by modern methods.  
Keywords: Neural stem cells, Differentiation, Maturation, Induced pluripotent stem cells, 
Neurodegenerative disease 
1. INTRODUCTION 
Stem cells are the unspecialized cells that have the potential to develop into different kinds of 
cells found in the body and it acts as an internal repair system. During the division of stem 
cells, each new cell has the capability either to become another type of cell or remain a stem 
cell. The remarkable characteristics of stem cells are the ability to renew themselves means 
making new copies through cell division and it can inactivate after some long period. They 
regularly divide in the bone marrow to either replace or regenerate damaged tissues also it has 
the capability to divide inside the Pancreas and Heart under special condition [1]. 
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Totipotent stem cells are the kind of stem cells, which can differentiate into all embryonic cell 
types and non-embryonic structure cell types such as placenta, and adult cell types, for 
example, fertilized egg cell- the first cell from this cell is by the cleavage not by stem cells, 
also they do not self-renew. Pluripotent stem cells can form all the cell types, which can be 
formed by totipotent except non-embryonic structures like yolk sac and placenta, for example, 
embryonic stem cells. Multipotent stem cells are found in specialized tissues of fetus and adult. 
They are capable of forming many tissues but not all the tissue cells of the body. Unipotent 
cells mean they can only differentiate into one cell type, for example, Spermatogonia can only 
give rise to sperms [2]. 
When embryo starts to develop, the totipotent fertilized egg start to moves onto the pluripotent 
state where the inner cell mass (ICM) of a blastocysts-stage embryo formed and continuously 
move to specialized cells, multipotent and unipotent cells stage. The Unipotent and multipotent 
cells are called progenitor cells. The dividing capacity of progenitor cell is limited [2]. 
According to the regenerative ability of stem cells, the medical industry uses this potential to 
cure the degenerative neural diseases which are referred as regenerative or reparative medicine 
[3]. The in vitro differentiated human embryonic stem cells (hESCs) is expected to replace the 
central nervous system (CNS) neurons since this is a most profitable way to suppress and 
prevent the neuronal disease [4]. 
 Neural stem cells (NSCs) are originating in the adult CNS and produces neural progenitor cells 
(NPCs) which can give rise to neurons and glial cells known as a combination of 
oligodendrocytes and astrocytes. To harvest the NSCs scientist have been used few days old 
embryonic stem cells, umbilical cord blood at the birth and the amniotic fluid. According to 
ethical issues, it has been banned in many countries to research with fetal tissues so the 
scientists are urged to find new sources and methods to isolate the NSCs and to differentiate 
them into neurons in vitro to successfully transplant the harvested neurons into a patient [2]. 
Non-neurogenic regions of the brain cannot produce neural stem cells therefore, the specific 
region of the brain derived from the donor or the other animal models and micro dissected, 
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cultured with highly enriched culture medium then differentiated and purified in vitro. This 
harvested NSCs used for therapeutic purpose and experiments [5]. 
In recent years, many different methods have been raised to culture the NSCs and NPCs to 
differentiate into neurons. I addition, new methods have been developing by researchers to 
culture and transplant the neurons into patients. There are no exact methods to grafting the 
laboratory-derived neurons into the recipient. If the neural replacement succeeded in the future, 
it can cure not only neuro degenerative diseases also psychiatric disorders, spinal cord injury, 
peripheral injury, blood tumors, epidermal and corneal disorder etc. [3, 6]. 
2. NEURAL STEM CELL BIOLOGY 
CNS is the origin of NSCs where two specific regions also are known as “neurogenic niches” 
give rise to NSCs and they are immature in adult and developing CNS [3]. The major cellular 
components of adult neurogenic niches are mature neurons, microglia, endothelial cells, 
ependymal cells, progenitor cells and astrocytes [7]. 
The two major neurogenic niches in the brain are a Subventricular zone (SVZ) and 
Hippocampal subgranular zone (SGZ). SGZ located in the dentate gyrus of the hippocampus 
where NSCs present in the lateral ventricle wall. Exclude these neurogenic niches the other 
regions of the brain can only generate glial cells [5, 8]. Non-neurogenic regions of the brain 
are Striatum, Optic nerve, Septum, Spinal cord, and neocortex also proliferating cells can be 
isolated from these regions and interestingly, they can generate neurons in vitro as well as in 
vivo when grafted into the neurogenic regions of the recipient [9]. Quiescent is the inactive 
NSCs (qNSCs) whereas aNSCs are the actively dividing NSCs both live in the neurogenic 
niches [10]. 
Stem cells express unique two kinds of genes identified as Sox2 and Oct4. The function of 
these genes is to promote other stem cell genes and to stop the associated genes of different 
cell types [11]. NSCs and NPCs are the cells which can proliferate and differentiate into 
multiple cell types but the proliferative capability is limited and it consists of all 
undifferentiated progeny of NSCs although it can be unipotent, bipotent or multipotent. 
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Intriguingly, it did not show the self-renewable ability [12]. According to the expression of 
unique markers and morphologies, there is two kinds of neural progenitors present in the SGZ 
which are known as Type 1 hippocampal progenitors (hp) also called as Astro-like NSCs and 
Type 2 hp. Type 1 hp express the Glial fibrillary acidic protein (GFAP), Astrocyte marker 
GFAP, transcription factor Sox2 which is important to regulate the stemness. Type 2-
hippocampal progenitor is believed that it can be raised from type 1 hp but it is not yet proven. 
Type 2 hp do not express GFAP and type 2 Sox2 positive cells can self-renew [13]. 
3. NEURAL STEM CELLS AND NEUROGENESIS 
3.1. Neurogenesis in embryo 
Neurogenesis in embryo occurs during embryogenesis. The initial process of neurogenesis is 
the induction of neuroectoderm later it forms the neural plate. Neural plate folds and makes the 
neural tube. Radial elongated Neuro epithelial progenitor cells (NEPs) start to appear as 
heterogeneous population inside the neural structures and they are complex. NEPs undergo 
symmetric divisions to expand NSC pools in the early stage of neurogenesis. In the second 
stage, NSCs turn on to asymmetric division cycles along with that generates the lineage-
restricted progenitors. Finally, NEPs convert into NSCs and NPCs. Glial restricted progenitors 
give rise to astrocytes and oligodendrocytes whereas NPCs give rise to neurons [12]. 
3.2. Neurogenesis in adult Mammalia 
Neurogenesis in adult referred as a generation of neurons from neural precursors the whole 
lifetime in restricted brain regions [7]. SGZ born neurons migrate into granule cell layer of the 
dentate gyrus and convert into dentate granule cells which are the principal neurons and they 
receive several of inputs from the different areas of the brain via neural peptides and 
neurotransmitters [13]. 
SVZ give birth to neurons and they migrate through the rostral migratory stream and develop 
into granule neurons and periglomerular neurons in the olfactory bulb. In adult Mammalia, the 
newborn neurons benefit plasticity of the brain and unite with existing circuitry to accept the 
functions [8, 13]. 
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4. TRADITIONAL NEURAL STEM CELL CULTURE 
4. 1. Traditional Neural stem cell culture methods 
In the past decades’ researchers thought that stem cells can be only harvested from developing 
embryo because induced pluripotent stem cells (iPSCs) and Embryonic stem cells (ESCs) 
permit the rise of NSCs population so they have been enhanced several in vitro techniques to 
differentiate the embryonic stem cell to NSCs [3,14]. The culture conditions for NSCs 
developed in early 90’s by the invention of mitogens; EGF and FGF-2 and this conditions 
allowed to extend the NSC cell division [3]. In 1981 the first ESCs were isolated from a mouse 
embryo [15]. Blastocyst stage of the mammalian embryo consists of inner cell mass (ICM) 
therefore ESCs are isolated from ICM [3]. 
4.1.1 Mouse embryonic fibroblast feeder layer method (MEF) 
James Thomson isolated the first human embryonic stem cells (hESCs) in 1998.This was done 
by transferring an embryonic ICM which was 3-5 days old onto a MEF layer of the mouse of 
and he cultured the hESCs on mouse embryonic fibroblast. Later these hESCs maintained in 
the neurospheres and differentiated into adult NSCs [16]. 
4.1.2. Technique to generate the neural differentiation in human embryonic stem cell 
Nerve growth factor (βNGF) and retinoic acid (RA) can potentially promote the neural 
differentiation in the ICM of blastocyst stage of the embryo. High concentration of RA and 
βNGF, dramatically increased the neuronal differentiation and no of neuronal cells meanwhile 
RA enhanced the neuronal process and production of neurons [14]. 
4.1.3. Amniotic fluid stem cell (AFS) isolation technique  
The rich source of multiple cell types is found in amniotic fluid. The heterogeneous AFS can 
give rise to multiple cell types. AFS cells can be directed into neural lineage by differentiation 
with nerve growth factors (NGF). AFS cells were derived from rodent and human AF and 
isolated by trypsinization method (using trypsin to dissociate cell) and allowed to expand in 
the culture. Then the suspension poured into NGF containing medium and induced to 
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differentiate into neural cells (i.e. Dopaminergic neuron). Multipotency of AFS cells clones 
was examined by the retro viral marking [14]. 
4.1.4. Neurosphere culture  
Reynolds and Weiss invent this method in 1992 to ensure the presence of NSCs in neurosphere. 
In addition, it has been using to examine the NSC characteristics such as self-renewal and 
Multipotency [3]. It is popular for examination of stem cell activity in vitro [17]. The initial 
step of this assay is a micro dissection of a selected region of CNS derived from Adult CNS, 
rodent brain or embryo. This is performed by either mechanical or enzymatically procedure. 
The dissected region is plated in the defined serum-free medium made up of mitogens such as 
EGF and bFGF. NSCs and NPCs start to divide and form primary neurosphere called “floating 
aggregates” [3, 12]. After 3 days, it forms small clusters of cells and this clusters detached and 
re-plated to give rise to the secondary neurospheres. These passages continue for many times 
to expand the NSC population. Several days after the NSCs and NPCs differentiate into neurons 
and glial cells then purify and measure the frequency of NSCs [2, 3]. 
4.1.5. Purification Technique-Flow cytometry 
This widely using technique is an essential part of NSC culture and purifies NSCs according 
to its granularity, antigen expression, and size. Some antigen markers can be detectable in this 
technique, which are EGFR, Nestin, CD 133, Lex, Sox2, and Musashi. This is only beneficial 
for identification of cell population, which can express markers [17]. 
4.2. Advantages of Traditional Neural stem cell culture methods 
ESCs allow producing vast number of neurons and interneurons in vitro and are capable to 
differentiate into all three germ layers. Compare to adult stem cells, the ESCs are easy to grow 
easily in culture medium also the population is phenotypically and genetically stable [18]. The 
benefit of neurosphere assay is testing NSCs for their properties in different conditions also 
allow to receive and expand aNSCs derivatives to test their properties in variable conditions. 
Neurosphere can be cultured for many passages up to 60 times and it may vary according to 
age and origin of tissue species [19]. 
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4.3. Errors in Traditional Neural stem cell culture methods 
In embryonic stem cell culture, the standard protocol for defined culture environment is poorly 
described [16]. In hESc neural differentiation method, it is difficult to generate homogeneous 
neuron cell culture due to absent of the lineage selection therefore to avoid this, genetically 
modified ESCs lines can be used [18]. The hESCs take weeks to form a culture with the daily 
maintenance so it consumes more time also they grow slowly in vitro and unable to decide 
whether the cells are pluripotent or stable. It is more difficult to assay cell frequency by 
characterization methods such as gene expression analysis, karyotyping, flow cytometry and 
immunocytochemistry. This technique provides limited expansion and cells try to lose 
differentiation and clonal capacity in the long-term passage [14]. Serum or conditioned medium 
is inappropriate to use in humans so there was a necessary to improve new culture protocols 
for adult NSCs also these old methods are technically challenging and labor intensive [9,16]. 
Neurosphere assay also has shown some errors in NSC technique evolution. When aNSCs grow 
in neurosphere assay, they may get altered in their properties during re-culture for more than 
10 times. Unfortunately, quiescent stem cells may not be identified by this assay also it does 
not allow to examine the bonafide stem cell population. Neurosphere assay has caveat so it 
cannot be accurately measured NSC frequency because it measures a false frequency of both 
NSCs and NPCs frequency due to unable of distinguishing the cell types according to this error 
Neurosphere assay is limited to use as a quantitative in vitro assay [17, 19]. In addition, 
utilization of hESCs led to the rise of ethical and political controversy. Some countries in the 
world banned the hESCs associated research. Ethics differ in each country according to their 
political and religious faith [20]. These ethical issues arise from the technology and the stem 
cell derivation methods used in the research [2]. The differentiation of pluripotent stem cells 
from embryo and oocyte is under the ethical policy, therefore, they have been derived from the 
reprogramming of somatic cells (i.e. Skin cells).These pluripotent stem cells are called induced 
pluripotent stem cells [20]. 
The hESCs research is involved in the abortion of human embryos so the application of hESCs 
is restricted by sharp ethical and political controversy. The high controversy has arisen in the 
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United States about the abortion of embryos. Scientists arguing that the embryo has the 
potential to become a live-born child when it is implanted into the uterus at the correct 
hormonal phase. Also argued, when the embryo implanted into a uterus, first it become fetus 
then only it develop into the live-born child. In some countries, people believe that the embryo 
has the same moral status as a human individual according to their cultural, religious and 
spiritual morals, therefore, derivation of embryonic stem cell lines from an embryonic ICM is 
considered as an extermination [2]. 
The alternative way is to derive embryos from a couple or women who had the infertility 
treatment known as In Vitro Fertilization (IVF). After the treatment, there will be some 
remaining frozen embryos so it can be donated to research rather than decide to destroy them. 
The couple or women must decide to donate according to the ethical laws and federal 
regulations. In addition, this is applicable for the fetal tissue donation after the abortion. 
Pluripotent stem cells can be derived from the donated fetal tissues. Presently, fetal-derived 
NSCs are used in Batten’s disease clinical trials which is a degenerative disease affecting the 
children [20]. 
The least ethical restrictions are permitted in several countries such as Belgium, Sweden, and 
the United Kingdom, to work with pluripotent stem cells but Germany only permit to work 
with adult stem cells and working with pluripotent stem cell is considered as a crime. Adult 
stem cells can be used in most of the countries for the research and clinical trials because they 
do not restrict by ethical controversies [2]. 
The European Union funded a database to Europe called Human Embryonic Stem Cell Registry 
(hESCreg) this help to access all the details about hESCs derived project details. 
5. MODERN NEURAL STEM CELL CULTURE 
5.1. Modern Neural stem cell culture methods 
Ethical issues for hESCs derives methods and lack of technology and stem cell knowledge was 
led to develop the modern methods [3]. 
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5.1.1. Adherent monolayer culture 
The defined serum-free medium used to culture CNS tissues. The medium is boosted with 
bFGF, EGF, Laminin or fibronectin and Substrate-Poly-L-ornithine, these supplements help in 
long-term culture of neural precursors. NSCs and NPCs adhere to the medium and forms a 
monolayer of cells. After the proliferation of cells. An Enzymatic treatment used to detach the 
cells from the culture surface and replaced another culture medium, which is as same as primary 
culture, and after long period cells undergo symmetric divisions. Cells induced into 
differentiating in to neurons and astrocytes by removing mitogens and kept under low serum-
containing medium [12]. 
5.1.2. Neural-colony forming cell assay  
It is developed to identify the high proliferative capability of stem cells than progenitor cells 
[17]. In addition, N-CFCA can distinguish stem cells from the progenitor cells based on their 
proliferative potential [20]. This is invented by Brent and Louis in 2008 [18]. The procedure 
starts with the suspension of a single cell into the plate at low cell density in a serum-free 
medium, which is composed of collagen and other essential factors. The collagen confirms the 
distinct colonies formed from single cells so this assay also known as the collagen-based semi-
solid assay. The medium inhibits the proliferation of NSCs and plated then leave for 21 days 
to generate colonies and colonies use to read the NSCs frequency. Finally, the equivalent no of 
colonies derives. The Research concluded that the growth conditions of N-CFCA do not inhibit 
the proliferation of adult or embryonic precursors. Instead of that, the time 21days enabled the 
high proliferative potential of cells to generate colonies with wide size distribution [21]. 
5.2. Errors in Modern Neural stem cell culture methods 
Adherent monolayer culture is not well organized to maintain NSCs in vitro and it produces 
the heterogeneous population of a cell, which is inappropriate for the transplantation [12]. N-
CFCA takes a long time to form colonies; therefore, it consumes time, labor cost and needs 
daily attention to maintain [21]. 
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6. ADVANCED NEURAL STEM CELL CULTURE METHODS 
Ongoing researchers and recent inventions play a major role in neural stem cell technology. 
6.1. Reprogramming of skin cells into induced pluripotent stem cells 
Very recently, the scientist used a technique to produce stem cells by reprogramming the skin 
cells to screen for tau-targeted therapy. The produced stem cells could differentiate into any 
kind of cell. The iPSCs are the most promising way to regenerate the Alzheimer’s disease and 
to produce a homogeneous population of neurons [11]. 
6.2. Hydrogel technique to promote neurogenesis 
In 2071, hydrogel used to induce the production of neurons. This method helps to differentiate 
NSCs into neurons and induce the rate of maturation. Hydrogel facilitates in its consistency 
and structure to modify and create similar properties of the human brain and this biomaterial 
has some elasticity as cerebral tissue. In addition, it contains the synthetic adhesive molecules 
“IKVAV” to accelerate the process of neuronal fate and neurogenesis and increases the chances 
to give rise to new neurons from NSCs. Hydrogel stiffness is as same as human brain so it 
facilitates the stimulation of neural development. The stiffness of hydrogel differently affects 
neurogenesis of embryonic and adult NSCs. The NPCs of embryo and adult stem cell 
progenitors accelerated by adjusting the hydrogel stiffness. The Bifunctional hydrogel is 
produced by combining the laminin peptide IKVAV renders and polylysine [22]. 
6.3. Clustered Regularly Interspaced Short Palindromic Repeats-genome activation 
method 
It is created to produce a large number of human brain cells to ease drug discovery. Scientists 
of Gladstone institute convert skin cells into stem cells by activating a specific gene using 
CRISPR technology and they induced the pluripotent cells from skin cells with the help of four 
key proteins those are transcription factors. They alter the responsible gene expression. The 
transcription factors switch off the skin cell-associated genes and switch on the genes that are 
responsible for stem cells. Thousands of genomic locations can be selected by one transcription 
factor and alter the gene expression at each location. Sox2 and Oct 4 are the responsible genes 
 
International Research Journal of Natural and Applied Sciences 
ISSN: (2349-4077)  
Impact Factor- 5.46, Volume 5, Issue 3, March 2018  
Website- www.aarf.asia, Email : editor@aarf.asia , 
editoraarf@gmail.com  
 
11 
 
to switch on other stem genes and to switch off those genes which are associated with other 
cell types [11]. 
This technique is an effective tool to create definite manipulation of a genome by the selection 
of unique DNA sequence. This single location target on the genome induce the natural chain 
reaction and result in reprogramming of skin cell into iPSCs [11]. 
6.4. Developing neural stem cell delivery method 
The delivery of harvested stem cells into therapy is limited and undeveloped. The limitation is 
due to the inaccurate injection site, the inability of cells to survive, inability to skip puncturing 
structures such as blood vessels, which create hemorrhage when penetrating into the brain. 
Scientist developing MRI-guided NSC delivering method to transplant the NSCs and it is 
expecting to solve the problems. This method is still at the research level and researchers 
working hard to make it successive [20]. 
7. ROLE OF NEURAL STEM CELLS IN NEURODEGENERATIVE DISEASES 
The common neurodegenerative disease is Parkinson’s disease (PD), Prion disease, 
Alzheimer’s disease (AD), motor neuron disease (MND), Spin cerebellar ataxia, Spinal 
muscular atrophy and Huntington's disease. 
7.1. Parkinson’s disease 
PD affects the area of brain named as ‘substansia nigra ’where dopaminergic neurons are rising. 
The dopamine is secreted by dopaminergic neurons which is important in contributing to a 
control movement pattern. PD patients may produce less dopamine or no dopamine due to 
degeneration of dopaminergic neuron consequently the dopaminergic neurons start to die and 
patients may experience the symptoms such as tremor, bradykinesia (slowed movement), and 
speech difficulty, write difficulty , rigid muscle, and constipation [23]. 
Scientists hope that the human dopaminergic neurons derived from the culture can be 
transplanted into PD patient. The transplanted neurons can be replaced the dopamine level and 
relieve symptoms of the disease also it will break the traditional treatments such as deep brain 
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stimulation and gene therapy. This idea was researched in 1994 by isolating fetal ventral 
mesencephalic tissue from aborted fetus which consists of high no of dopaminergic neuroblasts 
and was transplanted into PD patient. The grafted dopaminergic neurons survived and re-
innervated the striatum, unfortunately, the patient was led to the induced dyskinesia and this 
could be due to dopamine read over sensitized receptor or due to the non-dopaminergic region 
of the graft. According to ethical issues fetal-derived methods cannot be examined to solve this 
problem [23]. 
In 1995, Lorenz Studer cultured the dopaminergic cells from dividing progenitors from the 
fetus and it was transplanted into rats. After some days, symptoms were improved in the rat, 
which is affected by PD.Lorenz tried to transplant the cells into monkeys but he couldn’t send 
neurons from their birth region to effective region (the long extensions). He could be able to 
do this in rodent brain but that wasn’t easy in the animal brain because the brain is more 
complex and has long extensions. Nowadays researchers trying to transplant the neurons at 
their site of action instead transplanting into substansia nigra also they are working on to graft 
the NSCs into patients by performing advanced research techniques [2]. 
7.2. Alzheimer’s disease 
Alzheimer’s disease is a neuropsychiatric disorder also a neurodegenerative form of dementia 
(set of symptoms of memory loss and ability in thinking) and it caused by neurofibrillary 
tangles (NFTs) which led to the neuroinflammation and neuronal loss. The symptoms of this 
disease are confusion, loss of learning skill, difficulty in thinking and writing and increased 
loss of memory [20]. 
NSCs can be used to replace the lost neurons to regenerate. This may rebuild the lost key 
proteins and the neurons. The challenges of this transplantation therapy are epigenetic and 
genetic backgrounds of donor cells. The epigenetic memory of donor cell may cause abnormal 
cell stability gene expression. The Genetic defects can be caused some biochemical changes in 
the AD so before, glial and neuronal transplantation the DNA editing is necessary. CRISPR 
molecular scissor could be used to edit the donor’s cell [11, 24]. 
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It is difficult to select the specific location for transplantation throughout the CNS in AD patient 
because the false introduction may lead to tumors and rejection risks [20].  
7.3. Motor neuron disease 
The selective death of motor neurons occurs in this disease due to altered glial function, 
mitochondrial dysfunction, oxidative stress and other mechanisms. Unfortunately, non-neural 
cells also contributing to this disease mechanism [25]. 
Motor neurons can be isolated from human and rodent fetus this is a golden tool to validate the 
research but due to ethical issues, it is prohibited. Recently, mouse ESCs-derived motor 
neurons transplanted into the chick embryo and surprisingly, a tiny amount of axons extended 
into the periphery and formed neuromuscular junctions [25]. 
8. CONCLUSIONS 
NSCs have the potential to give rise to the neurons and glial cells so it was studied to generate 
in vitro and cultured to replace into a human brain. It is thought that the replaced neurons can 
work normally inside the brain and it will replace the degenerated neurons, unfortunately, there 
are no exact safety methods to transplant the cultured cells into the brain. The complexity and 
the long extensions of the mammalian brain give more challenges to be succeeded in this field.  
The restriction in fetal-derived stem cells for research delays and limit the development of new 
successive techniques to cure the disease, even though there are some least restricted ongoing 
research performed with human embryonic stem cells, which are legally derived from the 
donors. Recently scientists could produce homogeneous neuronal cells from genetically 
modified hESCs. One of the breathtaking successful is the derivation of stem cells from the 
non-neurogenic regions of the brain. Although several different sources have been used to 
isolate the NSCs among them the reprogrammed skin cell is more effective than the other 
sources because it is quicker, cheaper and can give more effective iPSCs. The protocols to 
expand the NSCs in vitro have been developing while the culture medium to grow and 
differentiate NSCs been improving and developing every year.  
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The Scientist working on a promising research to develop MRI-guided stem cell delivery 
method but before using on therapeutic purpose, scientists should unsolved the technical and 
neuropharmacological problems. They should develop the most appropriate in vitro methods 
to manipulate, to obtain the NSCs, and to derive the homogeneous culture of neuronal cells. 
They should investigate the no of cells, which are needed to be transplanted on the specific 
disease stage. Researchers should investigate the pharmacodynamics and pharmacokinetic 
effects of a mouse after the transplantation of neuronal cells into a diseased mouse. 
The field is moving forward to its destiny, new trials are continuously being planned and 
performed but none was successful. The neural stem cell therapy may get valid in the clinical 
therapeutics in the next decade. 
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